Prostate Cancer Support Group

Looking for Options for your Prostate Cancer?

If you are one of the 40,000 men treated for prostate cancer with radiation only to have their cancer return, then this clinical trial may be of interest to you.

This study might be appropriate if you:

• Are between the age of 40 and 85
• Have organ confined (biopsy confirmed) recurrent prostate cancer (Clinical Stages T1c and T2a)
• Have been treated with EBRT (conventional, 3D conformal, or IMRT) two or more years prior
• Have not had any prior medical or surgical treatment for prostate cancer, other than EBRT or hormone therapy
• Meet other protocol specific inclusion criteria

The purpose of this clinical research study is to evaluate the effectiveness of a study device, Sonablate® 500, which uses High Intensity Focused Ultrasound, HIFU, for the treatment of subjects who have locally recurrent prostate cancer. The high intensity focused ultrasound (sound wave energy) acts to destroy diseased tissue in the prostate. This treatment is radiation-free and has fewer side effects than other cancer treatments including hormone therapy.

The procedure is minimally invasive and is performed in an outpatient setting. You will be seen in the clinic a total of up to 10 times over 1 year, to ensure the procedure has been successful.

For more information or to determine if you qualify for this research opportunity, please call toll-free 1-866-619-6026 or visit www.theprostatecancerstudy.com/dai...
Posted on 10/15/09, 10:10 am